ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $9,188,000 | -10.3% | 69,849 | -12.1% | 0.03% | -22.7% |
| Q1 2021 | $10,246,000 | -34.4% | 79,508 | -15.1% | 0.04% | -41.3% |
| Q4 2020 | $15,610,000 | +8.1% | 93,600 | 0.0% | 0.08% | +1.4% |
| Q3 2020 | $14,444,000 | +4.3% | 93,600 | 0.0% | 0.07% | -7.5% |
| Q2 2020 | $13,843,000 | +27.8% | 93,600 | -2.7% | 0.08% | +14.3% |
| Q1 2020 | $10,833,000 | -17.6% | 96,200 | +1.8% | 0.07% | +6.1% |
| Q4 2019 | $13,146,000 | +88.3% | 94,500 | +30.3% | 0.07% | +73.7% |
| Q3 2019 | $6,983,000 | -19.1% | 72,500 | -3.3% | 0.04% | -20.8% |
| Q2 2019 | $8,636,000 | -2.2% | 75,000 | 0.0% | 0.05% | -5.9% |
| Q1 2019 | $8,827,000 | -42.1% | 75,000 | -69.2% | 0.05% | -46.3% |
| Q4 2018 | $15,243,000 | -21.3% | 243,306 | -11.0% | 0.10% | -7.8% |
| Q3 2018 | $19,361,000 | -18.1% | 273,237 | -23.1% | 0.10% | -24.3% |
| Q2 2018 | $23,637,000 | +1.7% | 355,348 | 0.0% | 0.14% | +3.0% |
| Q1 2018 | $23,239,000 | +63.3% | 355,348 | 0.0% | 0.13% | +69.2% |
| Q4 2017 | $14,235,000 | +10.5% | 355,348 | 0.0% | 0.08% | +5.4% |
| Q3 2017 | $12,881,000 | – | 355,348 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |